MDTResults are in8-K filed September 1, 2026

MDT Q1 2027 Earnings — Results Snapshot

Medtronic plc reported Q1 2027 results via an 8-K press release. This page preserves the snapshot available when the site was archived.

See the 8-K results summary Full earnings calendar

Results at a Glance

From the 8-K press release · filed Sep 1, 2026

Medtronic reported first quarter fiscal 2027 revenue of $9.756 billion, up 13.7% as reported and organic, with non-GAAP diluted EPS of $1.45 and GAAP diluted EPS of $1.14.

Revenue

$9.76B

vs est. $9.64B

Beat +1.2%

EPS (non-GAAP)

$1.45

vs est. $1.40

Beat +3.4%

Guidance

The company raised its fiscal 2027 organic revenue growth guidance to 7.25% to 7.75% and its fiscal 2027 diluted non-GAAP EPS guidance to $5.94 to $6.00.

Key takeaways from the release

Cardiovascular revenue was $3.927 billion, up 18.9% organic, with Cardiac Ablation Solutions growing 88%.
Neuroscience revenue was $2.678 billion, up 9.3% organic, and Medical Surgical revenue was $2.279 billion, up 10.2% organic.
Q1 non-GAAP operating margin was 23.7%, up 10 basis points, while GAAP operating margin was 18.1%, up 120 basis points.

Source: SEC Form 8-K (Item 2.02), EX-99.1 press release. Numbers are company-reported; estimates are Finnhub analyst consensus. This is a same-day snapshot — the full AI analysis (MD&A, risks, audit opinion) is generated automatically when the 10-Q/10-K is filed.

Want the full analysis the moment it's ready? Follow Medtronic plcand we'll notify you when it lands.

Want to save MDT for later?

Add MDT to your watchlist to keep its archived reports easy to find. New filing alerts are no longer sent.